Principales conclusions et analyse des parts de marché des médicaments antigrippaux d'ici 2025-2031
Anti-influenza Drugs Market Report Analysis
Anti-influenza Drugs Market
-
CAGR (2025 - 2031)6.8% -
Market Size 2024
US$ XX million -
Market Size 2031
US$ XX Million
Report Coverage
- Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Key future trends
- Detailed PEST/Porter’s Five Forces and SWOT analysis
- Industry landscape and competition analysis & recent developments
- Detailed company profiles
- Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
Key Players
- AstraZeneca plc
- BIOCRYST PHARMACEUTICALS, INC.
- DAIICHI SANKYO COMPANY, LIMITED.
- F. Hoffmann-La Roche Ltd
- GlaxoSmithKline plc.
- Mylan N.V.
- Novartis AG
- Sanofi
- Teva Pharmaceutical Industries Ltd.
Regional Overview
- Amérique du Nord
- Europe
- Asie-Pacifique
- Amérique du Sud et centrale
- Moyen-Orient et Afrique
Market Segmentation
By Type de produit
- péramivir
- zanamivir
- phosphate d'oseltamivir
- baloxavir marboxil
- autres produits
By Canal de distribution
- pharmacies de détail
- pharmacies hospitalières
- autres
By Géographie
- Amérique du Nord
- Europe
- Asie-Pacifique
- Amérique du Sud et centrale
- Moyen-Orient et Afrique
Get Free Sample For